Work

Immunological and Clinical Responses in Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma (MM) and Chronic Lymphocytic Leukemia (CLL) after RHAMM-R3 Peptide Vaccination.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.1806.1806

Authors: Jochen Greiner, Anita Schmitt, Krzysztof Giannopoulos, Jinfei Chen, Marlies Goetz, Markus Rojewski, Gerd Ritter, Sascha Gnjatic, Philippe Guillaume, Mark Ringhoffer, Martin Bommer, Richard F. Schlenk, Peter Liebisch, Donald Bunjes, Hiroshi Shiku, Hartmut Dohner, Michael Schmitt

Institutions: Universität Ulm, Ludwig Cancer Research, Ludwig Cancer Research, Mie University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2993666410

FWCI: 0.123

Cites:

Cited by: 1

Related to: 10